Healthcare Providers and Services
Company Overview of Dana-Farber Cancer Institute, Inc.
Dana-Farber Cancer Institute, Inc. provides cancer treatment and research services for adults and children in the United States. It offers services in the areas of blood, breast, cutaneous/skin, gastrointestinal, genitourinary, gynecological, head and neck, hematology, melanoma, neuro-oncology, sarcoma, and thoracic cancer aspects; and cancer genetics and prevention services. The company also provides services for blood disorders, brain tumors, stem cell transplantations, hematologic malignancies, and solid tumors. It offers its services through its cancer centers. Dana-Farber Cancer Institute, Inc. was formerly known as Sidney Farber Cancer Center and changed its name in 1983. The company w...
450 Brookline Avenue
Boston, MA 02215-5450
Founded in 1947
Key Executives for Dana-Farber Cancer Institute, Inc.
Chief Executive Officer and President
Chief Financial Officer and Senior Vice President for Finance
Chief Operating Officer and Executive Vice President
General Counsel, Senior Vice President and Assistant Secretary
Compensation as of Fiscal Year 2016.
Dana-Farber Cancer Institute, Inc. Key Developments
Dana-Farber Cancer Institute Appoints Larry Lucchino as Chairman of Jimmy Fund
Apr 20 16
Dana-Farber Cancer Institute appointed Larry Lucchino as Chairman of the Jimmy Fund. For the last 14 years, he has been president/CEO of the Boston Red Sox, and, after the 2015 season, was named Boston Red Sox President/CEO Emeritus. As Chairman of the Jimmy Fund, Lucchino, who is now also Chairman of the Pawtucket Red Sox, will be the lead ambassador and public spokesperson for the Jimmy Fund to strengthen relationships with the corporate community and professional sports teams, to strategize on policy and fundraising initiatives, and to recognize the many passionate donors and event participants. Lucchino will help increase awareness of the importance of philanthropic support for Dana-Farber and highlight the breakthroughs and milestones Dana-Farber doctors and researchers have achieved toward finding cures and treatments for cancer as a result of Jimmy Fund support.
Dana-Farber Cancer Institute, Inc. Presents at Sachs Associates 2nd Annual Immune-Oncology BD&L and Investment Forum, Jun-03-2016 01:50 PM
Mar 15 16
Dana-Farber Cancer Institute, Inc. Presents at Sachs Associates 2nd Annual Immune-Oncology BD&L and Investment Forum, Jun-03-2016 01:50 PM. Venue: Hyatt Chicago Magnificent Mile, 633 North Saint Clair Street, Chicago, IL 60611, United States. Speakers: Gary Sclar, Chief Research Business Development Officer.
Dana-Farber Cancer Institute Announces Executive Changes
Feb 23 16
Dana-Farber Cancer Institute annolunced that Laurie H. Glimcher, MD, has been named the next president and CEO of the Dana-Farber Cancer Institute. Glimcher is currently the Stephen and Suzanne Weiss Dean of the Medical College at Weill Cornell Medicine in New York City, where she is also professor of medicine and provost for medical affairs at Cornell University. Glimcher will begin at Dana-Farber in January, 2016 and current President Edward J. Benz, Jr., MD, has agreed to remain as president until her arrival at the Institute. She will also be a professor of medicine at the Harvard
Medical School. Prior to joining Weill Cornell Medicine, Glimcher was the Irene Heinz Given Professor of Immunology at the Harvard School of Public Health, and Professor of Medicine at Harvard Medical School, where she headed one of the top immunology programs in the world. Glimcher, a renowned immunologist and current dean of Cornell University's medical college, Weill Cornell Medicine, will replace Dr. Edward Benz, who is retiring after 16 years in the role. Benz will remain in the position until Glimcher arrives in January.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|